CA2552938A1 - Combinaison d'agonistes de l'adrenorecepteur beta2 de la benzothiazol-2-one et de corticosteroides dans le traitement des maladies respiratoires - Google Patents
Combinaison d'agonistes de l'adrenorecepteur beta2 de la benzothiazol-2-one et de corticosteroides dans le traitement des maladies respiratoires Download PDFInfo
- Publication number
- CA2552938A1 CA2552938A1 CA002552938A CA2552938A CA2552938A1 CA 2552938 A1 CA2552938 A1 CA 2552938A1 CA 002552938 A CA002552938 A CA 002552938A CA 2552938 A CA2552938 A CA 2552938A CA 2552938 A1 CA2552938 A1 CA 2552938A1
- Authority
- CA
- Canada
- Prior art keywords
- alkyl
- optionally substituted
- alkoxy
- hydroxy
- halo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0402797.5A GB0402797D0 (en) | 2004-02-09 | 2004-02-09 | Organic compounds |
GB0402797.5 | 2004-02-09 | ||
PCT/EP2005/001241 WO2005074924A1 (fr) | 2004-02-09 | 2005-02-08 | Combinaison d'agonistes de l'adrenorecepteur beta2 de la benzothiazol-2-one et de corticosteroides dans le traitement des maladies respiratoires |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2552938A1 true CA2552938A1 (fr) | 2005-08-18 |
Family
ID=31985893
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002552938A Abandoned CA2552938A1 (fr) | 2004-02-09 | 2005-02-08 | Combinaison d'agonistes de l'adrenorecepteur beta2 de la benzothiazol-2-one et de corticosteroides dans le traitement des maladies respiratoires |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1715860A1 (fr) |
JP (1) | JP2007522141A (fr) |
KR (1) | KR20060127974A (fr) |
CN (1) | CN1917875A (fr) |
AR (1) | AR047962A1 (fr) |
AU (1) | AU2005210140A1 (fr) |
BR (1) | BRPI0507544A (fr) |
CA (1) | CA2552938A1 (fr) |
GB (1) | GB0402797D0 (fr) |
PE (1) | PE20050692A1 (fr) |
RU (1) | RU2006132195A (fr) |
TW (1) | TW200536533A (fr) |
WO (1) | WO2005074924A1 (fr) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200738658A (en) | 2005-08-09 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
TW200738659A (en) * | 2005-08-29 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
TW200740781A (en) * | 2005-08-29 | 2007-11-01 | Astrazeneca Ab | Novel compounds |
JP5257073B2 (ja) * | 2005-11-10 | 2013-08-07 | ボーダー、ニコラス・エス | ソフト型抗コリン作動性エステル |
GB0601951D0 (en) | 2006-01-31 | 2006-03-15 | Novartis Ag | Organic compounds |
TW200745067A (en) * | 2006-03-14 | 2007-12-16 | Astrazeneca Ab | Novel compounds |
TW200833670A (en) | 2006-12-20 | 2008-08-16 | Astrazeneca Ab | Novel compounds 569 |
GB0702458D0 (en) | 2007-02-08 | 2007-03-21 | Astrazeneca Ab | Salts 668 |
GB0702456D0 (en) * | 2007-02-08 | 2007-03-21 | Astrazeneca Ab | New combination |
EP2011534A1 (fr) * | 2007-07-03 | 2009-01-07 | CHIESI FARMACEUTICI S.p.A. | Actionneur d'inhalateur à dosage mesuré |
CN101878221B (zh) | 2007-11-30 | 2014-04-02 | 辉瑞有限公司 | 糖皮质激素受体激动剂 |
EP2534957B1 (fr) | 2007-12-14 | 2015-05-27 | AeroDesigns, Inc | Administration de produits sous forme d'aérosols |
WO2009087224A1 (fr) | 2008-01-11 | 2009-07-16 | Novartis Ag | Pyrimidines utilisés en tant qu'inhibiteurs de kinase |
WO2009154557A1 (fr) | 2008-06-18 | 2009-12-23 | Astrazeneca Ab | Dérivés de benzoxazinone agissant comme agoniste des récepteurs bêta2-adrénergiques pour le traitement de troubles respiratoires |
WO2011061527A1 (fr) | 2009-11-17 | 2011-05-26 | Astrazeneca Ab | Combinaisons qui comprennent un modulateur du récepteur glucocorticoïde, destinées au traitement de maladies respiratoires |
WO2012034095A1 (fr) | 2010-09-09 | 2012-03-15 | Irm Llc | Composés et compositions comme inhibiteurs de trk |
US8637516B2 (en) | 2010-09-09 | 2014-01-28 | Irm Llc | Compounds and compositions as TRK inhibitors |
GB201016912D0 (en) | 2010-10-07 | 2010-11-24 | Astrazeneca Ab | Novel combination |
MA34969B1 (fr) | 2011-02-25 | 2014-03-01 | Irm Llc | Composes et compositions en tant qu inibiteurs de trk |
JO3192B1 (ar) * | 2011-09-06 | 2018-03-08 | Novartis Ag | مركب بنزوثيازولون |
KR20220119529A (ko) | 2016-06-02 | 2022-08-29 | 애브비 인코포레이티드 | 글루코코르티코이드 수용체 작용제 및 이의 면역접합체 |
WO2019106609A1 (fr) | 2017-12-01 | 2019-06-06 | Abbvie Inc. | Agoniste du récepteur des glucocorticoïdes et immunoconjugués de celui-ci |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999009018A1 (fr) * | 1997-08-14 | 1999-02-25 | Kirin Beer Kabushiki Kaisha | DERIVES DE BENZOTHIAZOLONE PRESENTANT UNE ACTIVITE SELECTIVE D'AGONISTE DU RECEPTEUR β2 |
PE20050130A1 (es) * | 2002-08-09 | 2005-03-29 | Novartis Ag | Compuestos organicos |
-
2004
- 2004-02-09 GB GBGB0402797.5A patent/GB0402797D0/en not_active Ceased
-
2005
- 2005-02-05 TW TW094103838A patent/TW200536533A/zh unknown
- 2005-02-08 EP EP05707254A patent/EP1715860A1/fr not_active Withdrawn
- 2005-02-08 CA CA002552938A patent/CA2552938A1/fr not_active Abandoned
- 2005-02-08 JP JP2006551821A patent/JP2007522141A/ja active Pending
- 2005-02-08 AU AU2005210140A patent/AU2005210140A1/en not_active Abandoned
- 2005-02-08 CN CNA2005800044314A patent/CN1917875A/zh active Pending
- 2005-02-08 RU RU2006132195/15A patent/RU2006132195A/ru not_active Application Discontinuation
- 2005-02-08 WO PCT/EP2005/001241 patent/WO2005074924A1/fr active Application Filing
- 2005-02-08 BR BRPI0507544-0A patent/BRPI0507544A/pt not_active IP Right Cessation
- 2005-02-08 KR KR1020067016003A patent/KR20060127974A/ko not_active Application Discontinuation
- 2005-02-09 AR ARP050100452A patent/AR047962A1/es not_active Application Discontinuation
- 2005-02-09 PE PE2005000154A patent/PE20050692A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR047962A1 (es) | 2006-03-15 |
WO2005074924A1 (fr) | 2005-08-18 |
BRPI0507544A (pt) | 2007-06-12 |
PE20050692A1 (es) | 2005-11-15 |
KR20060127974A (ko) | 2006-12-13 |
EP1715860A1 (fr) | 2006-11-02 |
RU2006132195A (ru) | 2008-03-20 |
AU2005210140A1 (en) | 2005-08-18 |
CN1917875A (zh) | 2007-02-21 |
TW200536533A (en) | 2005-11-16 |
GB0402797D0 (en) | 2004-03-10 |
JP2007522141A (ja) | 2007-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2552938A1 (fr) | Combinaison d'agonistes de l'adrenorecepteur beta2 de la benzothiazol-2-one et de corticosteroides dans le traitement des maladies respiratoires | |
CA2427282C (fr) | Composes organiques ou melanges pour le traitements des maladies des voies respiratoires | |
US20080286363A1 (en) | Pharmaceutical Compositions for the Treatment of Inflammatory and Obstructive Airways Diseases | |
EP3603634A1 (fr) | Composition pharmaceutique comprenant du glycopyrrolate et un agoniste du récepteur beta2 adrénergique | |
AU2006314724A1 (en) | Organic compounds comprising a glycopyrronium salt | |
CA2659339A1 (fr) | Composes organiques destines au traitement de maladies inflammatoires ou des syndromes obstructifs | |
EP1957072A1 (fr) | Methode pour traiter l'asthme et les maladies pulmonaires obstructives chroniques en utilisant une therapie a triple combinaison | |
MXPA06008966A (en) | Combination of benzothiazol-2-one beta2 adrenoceptor agonists and corticosteroids for the treatment of respiratory diseases | |
AU2007217704A1 (en) | Combinations of steroids and methylxanthine compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |